Sort by
Refine Your Search
-
Listed
-
Country
-
Employer
- Institute of Organic Chemistry Polish Academy of Sciences
- Universitat de Barcelona
- Rutgers University
- Stanford University
- Adam Mickiewicz University, Poznań
- Chalmers University of Technology
- FAPESP - São Paulo Research Foundation
- FEUP
- FUNDACIÓN PARA LA INVESTIGACIÓN MÉDICA APLICADA
- Fundación IIS Aragón
- Ghent University
- Indiana University
- Institute of Physics, Zagreb
- International Institute of Molecular and Cell Biology in Warsaw
- Luxembourg Institute of Science and Technology
- Maj Institute of Pharmacology Polish Academy of Sciences
- Nature Careers
- SWPS University
- Universidade Católica Portuguesa - Porto
- Universidade Nova de Lisboa
- University College Dublin
- University of Florida
- University of North Carolina at Chapel Hill
- University of Split, Faculty of civil engineering, architecture and geodesy
- University of Trás-os-Montes and Alto Douro
- University of Washington
- Vanderbilt University
- École nationale des ponts et chaussées
- 18 more »
- « less
-
Field
-
at the Center for Development of Gene Therapies TREAT-EXP in the project FENG.02.01-IP.05-M038/25, TREAT-EXP: Development of therapeutic strategies for human genetic diseases caused by nucleotide repeat
-
of the Regulation of the Research Grants from FCT, IP - Regulation no. 950/2019, of 16 December, which will not exceed, with the scholarship contract in question, including possible renewals, an accumulated period of
-
generation of dually loaded self-assembled peptide lipid nanoparticles enabling glaucoma neuroprotection. IP: Elena Sánchez López Research group: Nanostructurated Systems for controlled drug release
-
: Law N.º 40/2004, of 18 August (Statute of Scientific Research Fellow), amended by DL 123/2019 of 28 August; FCT, IP Research Grant Regulation, approved by Regulation N.º 234/2012, published in the II
-
an entrepreneurial role, with demonstrated success in setting up, financing, and scaling a spin-off/start-up. Solid knowledge of IP strategies, business models, and commercialization of technologies in the broader
-
)” in the Laboratory of Neuropharmacology and Epigenetics, Department of Drug Addiction Pharmacology, Maj Institute of Pharmacology Polish Academy of Sciences (IP PAS or Institute), to conduct research as
-
cells and human iPS cells, as well as with genetically modified mouse and pig models. Last publications: https://pubmed.ncbi.nlm.nih.gov/40551151/ https://pubmed.ncbi.nlm.nih.gov/37967560/ https
-
-activated cell sorting (FACS), and immunoprecipitation (IP). Maintains and differentiates human induced pluripotent stem cells (iPSCs) into specific cell lineages using established protocols and assist with
-
of IP processes and knows how to protect findings. Selection process https://www.ucd.ie/workatucd/jobs/ Website for additional job details https://www.ucd.ie/ Work Location(s) Number of offers
-
. - Collaborate with a multidisciplinary team and industry partners. - Present results and contribute to publications. Where to apply Website https://t.ly/wxZC_ Requirements Research FieldBiological